← All trials
NCT05203744
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 10, 2022
- Primary completion
- Dec 3, 2022
- Completion date
- Dec 3, 2022
- First posted
- Jan 24, 2022
- Last posted
- Apr 11, 2022
- Enrollment
- 200
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- United States NavyLead sponsor
- Government of AustraliaOverall official - principal investigator
- Government of AustraliaCollaborator
- Government of AustraliaOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.